Effect of Rivaroxaban vs Enoxaparin on Major Cardiac Adverse Events and Bleeding Risk in the Acute Phase of Acute Coronary Syndrome
Long-Term Treatment with the Combination of Rivaroxaban and Aspirin in Patients with Chronic Coronary or Peripheral Artery Disease: Outcomes During the Open Label Extension of the COMPASS trial
Mortality Benefit of Rivaroxaban Plus Aspirin in Patients With Chronic Coronary or Peripheral Artery Disease
Postprocedural Anticoagulation After Primary Percutaneous Coronary Intervention for ST-Segmentâ€“Elevation Myocardial Infarction: A Multicenter, Randomized, Double-Blind Trial
Warfarin, Aspirin, or Both after Myocardial Infarction
